SCHEMBL21532544

SCHEMBL21532544

c1ccc(-c2nnc(-c3cccc4c5ccccc5n(-c5ccccc5-c5ccccc5-n5c6ccccc6c6ccc7c8ccccc8oc7c65)c34)n2-c2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 2/20 0.36
TSHR P16473 1/20 0.36
AKT1 P31749 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.34
ATM Q13315 1/20 0.34
AVPR1A P37288 1/20 0.34
ALOX5 P09917 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HPGD P15428 1/20 0.33
HSD11B1 P28845 1/20 0.32
PRKDC P78527 1/20 0.32
DRD4 P21917 1/20 0.31
PPARG P37231 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
NR2E3 Q9Y5X4 1/20 0.31
NCOR2 Q9Y618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532619 0.97 KDM4E (0.37) KDM4EALDH1A1HSD17B10TSHRAKT1
SCHEMBL21532256 0.93 ALOX5 (0.34) KDM4EALDH1A1HSD17B10TSHRAKT1
SCHEMBL21532541 0.93 KDM4E (0.33) KDM4EALDH1A1HSD17B10TSHRAKT1
SCHEMBL21532534 0.92 AVPR1A (0.35) KDM4EALDH1A1HSD17B10TSHRAKT1
SCHEMBL21532709 0.92 ALDH1A1 (0.36) KDM4EALDH1A1HSD17B10TSHRL3MBTL1
SCHEMBL21532469 0.91 ALDH1A1 (0.33) KDM4EALDH1A1HSD17B10TSHRAKT1
SCHEMBL21532304 0.91 ALDH1A1 (0.36) KDM4EALDH1A1HSD17B10TSHRL3MBTL1
SCHEMBL23911753 0.91 AKT1 (0.38) KDM4EALDH1A1HSD17B10AKT1ALOX5
SCHEMBL21532685 0.90 KDM4E (0.34) KDM4EALDH1A1HSD17B10TSHRAKT1
SCHEMBL21532553 0.90 KDM4E (0.34) KDM4EALDH1A1HSD17B10TSHRAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 KDM4E 4144/4885ALDH1A1 158/4885HSD17B10 2103/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 KDM4E 3893/4885ALDH1A1 283/4885HSD17B10 2716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.